Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
3D Biotek is a high-tech biotechnology company specializing in the development and commercialization of novel 3D cell culture technologies. The company provides a variety of 3D cell culture scaffolds, such as the 3D Insert, which are designed to mimic the in vivo microenvironment for improved cell growth and differentiation. Their products are widely used in tissue engineering, drug screening, and stem cell research to enhance the physiological relevance of in vitro assays. By offering both synthetic and biodegradable materials, 3D Biotek supports researchers in transitioning from traditional 2D cultures to more accurate 3D models. Additionally, the company offers specialized bioreactor systems for automated and scaled cell expansion.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 3D Biotek.